PCM
KIDS icon

Prelude Capital Management’s OrthoPediatrics KIDS Stock Holding History

Prelude Capital Management’s Portfolio KIDS Stock Details KIDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-900
Closed -$14K – 1801
2018
Q1 		$14K Buy
+900
New +$15.9K ﹤0.01% 1302

Other funds holding KIDS

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Prelude Capital Management's KIDS Position: Q2 2018 in Review

Prelude Capital Management sold out of OrthoPediatrics (KIDS) in Q2 2018, closing a stake of 900 shares — an estimated $14K sold.

Prelude Capital Management first reported a position in KIDS in Q1 2018 and held it in 1 quarter. The position peaked at $14K in Q1 2018. 56 funds tracked by Wall St. Rank hold KIDS as of Q2 2018.

  • Prelude Capital Management reported no remaining OrthoPediatrics position as of Q2 2018 after selling out during the quarter.
  • Prelude Capital Management sold 900 OrthoPediatrics shares in Q2 2018, an estimated $14K.
  • Prelude Capital Management first reported a position in OrthoPediatrics in Q1 2018 and held it in 1 quarter.
  • Prelude Capital Management's OrthoPediatrics position peaked at $14K in Q1 2018.
  • 56 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2018.

Based on Prelude Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.